Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001437749-21-006677
Filing Date
2021-03-22
Accepted
2021-03-22 07:30:34
Documents
6
Effectiveness Date
2021-03-22

Document Format Files

Seq Description Document Type Size
1 FORM S-3MEF atos20210318_s3mef.htm S-3MEF 56217
2 EXHIBIT 5.1 OPINION OF GIBSON, DUNN & CRUTCHER LLP ex_235148.htm EX-5.1 6239
3 EXHIBIT 23.1 AUDITORS' CONSENT ex_235153.htm EX-23.1 3705
4 letter01.jpg GRAPHIC 3099
5 letter02.jpg GRAPHIC 9778
6 letter03.jpg GRAPHIC 4571
  Complete submission text file 0001437749-21-006677.txt   91625
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-254548 | Film No.: 21759908
SIC: 2834 Pharmaceutical Preparations